A high-pressure liquid chromatographic method has been developed for the quantitative determination of rosaramicin in serum. This procedure involves addition of an internal standard, adjustment to alkaline pH, treatment with potassium carbonate, ether extraction, and a reverse-phase column separation with acetonitrile-acetate buffer mixture as the mobile phase. This technique produces a good linear relationship between the peak height ratio and the rosaramicin concentration. In addition, this method has proven to be quite specific for rosaramicin, since many of its derivatives tested do not interfere with the assay. The method is accurate and reproducible with a sensitivity of about 0.01 tg of rosaramicin per ml of serum. It may be useful in monitoring drug levels in serum of patients and also for the pharmacokinetic studies of the drug in humans.
A high-pressure liquid chromatographic method has been developed for the quantitative determination of rosaramicin in serum. This procedure involves addition of an internal standard, adjustment to alkaline pH, treatment with potassium carbonate, ether extraction, and a reverse-phase column separation with acetonitrile-acetate buffer mixture as the mobile phase. This technique produces a good linear relationship between the peak height ratio and the rosaramicin concentration. In addition, this method has proven to be quite specific for rosaramicin, since many of its derivatives tested do not interfere with the assay. The method is accurate and reproducible with a sensitivity of about 0.01 tg of rosaramicin per ml of serum. It may be useful in monitoring drug levels in serum of patients and also for the pharmacokinetic studies of the drug in humans.
Rosaramicin is a micromonospora-produced macrolide antibiotic with activity against both gram-positive and gram-negative bacteria (1, 3, 7) . After oral or intravenous administration, plasma and serum concentrations ofrosaramicin in humans (1) and laboratory animals (1, 6) were low and often below the detectable limits of a microbiological assay (0.1 to 0.2 ,ug/ml). RESULTS AND DISCUSSION Recently, the HPLC methods have been used to determine the plasma and serum concentrations of antibiotics such as netilmicin (4), tobramycin (2) and erythromycin (5) . These methods involve tedious extraction and precolumn or postcolumn derivatization. The present paper describes a simple and sensitive HPLC assay for a new macrolide antibiotic, rosaramicin, in human serum. serum and serum from subjects receiving rosaramicin. The retention times for rosaramicin and desepoxyrosaramicin were 16 and 19 min, respectively. These are clearly different from the retention times ofrosaramicin analogs ( Table 1 ), indicating that the HPLC method measures rosaramicin specifically, and the derivatives tested do not interfere with the measurement of rosaramicin. We have also shown that rosaramicin has a retention time different from those of common drugs ( Table 1) .
The standard curve for rosaramicin was obtained by plotting the ratio of peak height of rosaramicin to the peak height of desepoxyrosaramicin against the concentrations of rosaramicin. As shown in Fig. 1 , a good linear relationship was obtained between the peak height ratio and the drug concentrations ranging from 0.05 to 4.00 Ag/ml.
The recovery of rosaramicin from serum was found to be about 86%. We have also estimated the sensitivity of the HPLC method to be about 0.01 ,ug/ml. Such an excellent sensitivity is due to the presence of an a,fl-unsaturated ketone, a strong chromophore for ultraviolet absorption in the rosaramicin molecule.
To evaluate the within-day reproducibility of the method, six 1-ml serum samples were spiked with 0.25 jig of rosaramicin, and six serum samples were spiked with 0.50 ug of the drug. The samples were extracted as described above and injected into an HPLC column. The results (Table 2) show that the HPLC method was accurate with good reproducibility. As shown in Table 3 , the between-day reproducibility of the method was also quite impressive.
To investigate the feasibility of using the HPLC method for measuring rosaramicin in human serum, we analyzed serum samples from 12 volunteers after oral administration of two rosaramicin tablets (250-mg tablets). b Ratio of peak height for rosaramicin to peak height for deseproxyrosaramicin. The rosaramicin levels reached a maximum of 0.448 jig/ml at about 1.5 h after drug administration. Thereafter, the drug concentrations decreased rapidly with time. At 12 h after dosing, a mean serum concentration of 0.076 ,ug/ml was readily measured, since this value is well above the sensitivity of the HPLC method (0.010 to 0.020 ,ug/ml).
The serum samples were also measured for rosaramicin levels by a microbiological method which was performed by disk diffusion assay technique, using Mueller-Hinton agar medium (Difco), seeded with B. subtillis ATCC 6633 (6) .
From 0 to 6 h after dosing, the mean values of the microbiological assay (Fig. 3) were slightly lower but gave a pattern similar to that obtained with the HPLC method. For these time periods, a good correlation was obtained for the mean values of the two methods; the linear regression analysis gave an equation of Y = 0.8926X + 0.09035, with a correlation coefficient of 0.9684 (Fig. 4) . However, after the 6-h period, the mean values for the microbiological assay were appre- ciably lower than those from the HPLC method (Fig. 4) . This was due to the sensitivity limit of the microbiological assay (0.100 to 0.200 ,ug/ml), which is 10 times lower than that of the HPLC method (0.010 to 0.020 ,ug/ml).
In addition to the sensitivity limitation, the microbiological assay measures not only rosaramicin, but also metabolites which are biologically active. This would limit the microbiological assay to situations where the quantity of the active metabolites is negligible, which excludes its utility in the analysis of body fluids (e.g., urine) where the amount of biologically active substances, in addition to rosaramicin, are rather high (unpublished data). The HPLC, on the other hand, is specific for rosaramicin and thus permits the quantitative analysis of rosaramicin in the body fluids.
The HPLC method for determination of rosaramicin described in this communication is specific, sensitive, accurate, and reproducible.
The method may be useful in therapeutic drug monitoring and assessment as well as in pharmacokinetic studies.
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